Is Aspirin Still Indispensable After PCI-Rethinking Dual Antiplatelet Therapy in Contemporary Practice. [PDF]
Yadav K +6 more
europepmc +1 more source
Clopidogrel, an ADP-P2Y12 Receptor Antagonist, Is Associated With Lower Opioid Consumption and a Reduced Incidence of Delirium in Cancer Patients Receiving Chemotherapy: A Nationwide Retrospective Cohort Study in Japan. [PDF]
Abe H +9 more
europepmc +1 more source
Bleeding complications in patients with out-of-hospital cardiac arrest treated with cangrelor and oral P2Y12 inhibitors. [PDF]
Gelbenegger G +12 more
europepmc +1 more source
Comparison of P2Y<sub>12</sub> inhibitors vs. aspirin monotherapy following dual antiplatelet therapy in patients after percutaneous coronary intervention: a systematic review and meta-analysis. [PDF]
Kazmi MH +17 more
europepmc +1 more source
Patterns of antithrombotic treatment after left atrial appendage occlusion. [PDF]
Liu X +5 more
europepmc +1 more source
Association of P2Y12 G52T genetic polymorphism with recurrent thromboembolic events in stroke and myocardial infarction patients on clopidogrel therapy: a prospective observational study. [PDF]
Baiju A +17 more
europepmc +1 more source
The DRY motif at work: the P2Y12 receptor case [PDF]
G. Rovati, V. Capra
openaire +2 more sources
Clopidogrel vs. Aspirin in Double Antithrombotic Therapy for Patients on Oral Anticoagulation Undergoing Coronary Stenting. [PDF]
Pompei G +7 more
europepmc +1 more source
Phytochemical Profiling, Antiplatelet Potential, and Cytotoxic Assessment of Thymelaea tartonraira Aerial Part Essential Oil: In Vitro and In Silico Studies. [PDF]
Soltani S +8 more
europepmc +1 more source
Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. [PDF]
Navarese EP +12 more
europepmc +1 more source

